Acute myeloid leukemia (AML): What it is, how it’s treated and what’s on the horizon 

In this session, Dr. Ryan Stubbins, fellow at the BC Cancer Genome Sciences Centre and the Leukemia/BMT Program of BC, discussed what AML is, how it develops, how it is treated, and some of the most promising new treatments for the disease.